RE:RE:RE:Zero confidence in this CEOThe only thing grail has is oodles of investors money to blow on pr, our product speaks for itself. The medical community and cancer community can't and won't take 50% guesses at cancer because that's what we're already doing, stagezero knows that and they're playing to win long term with a product that doesn't leave room for doubt. Grails short term press blitzing is nothing new, and the unimpressive data hasn't changed. Either way, they bring attention to our market anyway like you said. Let them spend all the money on press and get everyone's attention, then stage can spend a few pennies and send out a couple flyers saying " if you liked 50%, boy have we got a product for you."